NEW YORK / LONDON (IT BOLTWISE) – US investment bank Goldman Sachs has maintained its buy rating on Bayer despite the ongoing legal disputes over glyphosate. A significant step could be the acceptance of a ruling by the US Supreme Court, which could significantly reduce the burden on Bayer. A decision is expected by June 2026, which could affect the share price.
Today’s daily deals at Amazon! ˗ˋˏ$ˎˊ˗
The US investment bank Goldman Sachs has reiterated its buy recommendation for Bayer with a price target of EUR 38.50. This decision comes despite the ongoing legal disputes over the controversial weedkiller glyphosate, which has plagued Bayer since it took over Monsanto. Analyst James Quigley sees the U.S. Attorney General’s support for a Supreme Court review of the glyphosate ruling as a crucial step. If the Supreme Court accepts the ruling, this could reduce the legal uncertainties for Bayer.
The acceptance of the case by the US Supreme Court is seen as a far-reaching step that offers the opportunity to finally put an end to the burdens of the legal disputes. A decision from the Supreme Court is expected by the end of June 2026, as the composition of the court will then change. This deadline puts pressure on Bayer to find a solution that could stabilize its share price.
The legal disputes over glyphosate have burdened Bayer for years and led to significant financial provisions. The outcome of the case could not only affect Bayer’s financial situation, but also have an impact on the entire agrochemical sector. A positive verdict could pave the way for a revaluation of Bayer shares and increase investor confidence.
Goldman Sachs remains optimistic that Bayer is well positioned for the long term despite the challenges surrounding glyphosate. The investment bank sees potential in Bayer’s other business areas, particularly in the pharmaceutical and healthcare sectors. These areas could help offset the negative impact of the glyphosate litigation and support the company’s growth.
Order an Amazon credit card without an annual fee with a credit limit of 2,000 euros!
Bestseller No. 1 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 2 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 3 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 4 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 5 ᵃ⤻ᶻ “KI Gadgets”
Please send any additions and information to the editorial team by email to de-info[at]it-boltwise.de. Since we cannot rule out AI hallucinations, which rarely occur with AI-generated news and content, we ask you to contact us via email and inform us in the event of false statements or misinformation. Please don’t forget to include the article headline in the email: “Goldman Sachs sees potential for Bayer despite glyphosate litigation”.
The post Goldman Sachs sees potential for Bayer despite glyphosate litigation appeared first on Veritas News.
